Heartflow (NASDAQ:HTFL) CEO Sells $1,361,500.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 27,230 shares of Heartflow stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $50.00, for a total value of $1,361,500.00. Following the completion of the transaction, the chief executive officer directly owned 360,814 shares of the company’s stock, valued at approximately $18,040,700. This trade represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Tuesday, August 18th, John C.M. Farquhar sold 32,676 shares of Heartflow stock. The shares were sold at an average price of $45.00, for a total value of $1,470,420.00.
• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.75, for a total value of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Stock Down 1.7%

Heartflow stock opened at $48.10 on Friday. The company has a market capitalization of $4.18 billion and a PE ratio of -26.28. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $51.19. The firm’s fifty day moving average is $31.97 and its 200 day moving average is $28.93.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million during the quarter. The business’s revenue for the quarter was up 47.7% compared to the same quarter last year. Sell-side analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Piper Sandler reaffirmed an “overweight” rating and set a $45.00 price target (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Freedom Capital raised Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. William Blair initiated coverage on Heartflow in a research report on Monday, May 4th. They set an “outperform” rating on the stock. Morgan Stanley increased their target price on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a report on Friday, August 14th. Finally, Canaccord Genuity Group lifted their price target on shares of Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Heartflow has a consensus rating of “Moderate Buy” and an average price target of $43.43.

Hedge Funds Weigh In On Heartflow

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Heartflow during the fourth quarter valued at approximately $27,000. Russell Investments Group Ltd. purchased a new position in Heartflow in the fourth quarter worth $45,000. Essential Partners LLC purchased a new position in Heartflow in the first quarter worth $57,000. Legal & General Group Plc bought a new position in Heartflow in the 3rd quarter valued at $59,000. Finally, Strs Ohio purchased a new stake in shares of Heartflow during the 4th quarter valued at $99,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.